Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Letter From the Editors: Are We Prepared for the Genomics Era?
1
x
$
0.00
Surgical Management of Epithelial Ovarian Cancer
1
x
$
0.00
Spontaneous Ejaculation Induced with Atomoxetine (OPEN ACCESS)
1
x
$
0.00
Captagone & Morbid Jealousy
1
x
$
30.00
Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study
1
x
$
30.00
Letter From the Editors: Right Tool, Right Time, Right Reason
1
x
$
0.00
Neuropsychiatric Update: Neuroimaging Schizophrenia
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
1
x
$
30.00
Psiquiatría social: Las mujeres centroamericanas y la psiquiatría
1
x
$
0.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Development of STI571 and Its Use in Chronic Myelogenous Leukemia and Other Malignancies
1
x
$
0.00
Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal- Amplified Flow Cytometry
1
x
$
30.00
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
1
x
$
30.00
VOL 3 No. 3 Full Issue - March 2001
1
x
$
20.00
Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant Schizophrenia
1
x
$
30.00
Misdiagnosis of Catatonia (OPEN ACCESS)
1
x
$
0.00
View Cart
Checkout
Home
Store
“Misdiagnosis of Catatonia (OPEN ACCESS)” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Consecuencias psicosociales de la depresión adolescente
$
0.00
Add to cart
Details
Consequences of 1,4-Butanediol Misuse: A Review
$
30.00
Add to cart
Details
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
$
0.00
Add to cart
Details
Contemporary Management of Alzheimer’s Disease
$
30.00
Add to cart
Details
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
$
30.00
Add to cart
Details
Coping With Somatic Comorbidities: Striving for Complete Recovery
$
30.00
Add to cart
Details
Cornell Scale for Depression in Dementia
$
0.00
Add to cart
Details
Corrections to: Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence.
Details
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Critical Analysis of Recent Phase III Studies for the Treatment of Colorectal Cancer Implications for Future Clinical Trial Design
$
10.00
Add to cart
Details
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
DASS21
$
0.00
Add to cart
Details
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
Add to cart
Details
David C. Steffens, MD, MHS: The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) Approach
$
30.00
Add to cart
Details
David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Previous
1
…
9
10
11
…
44
Next
Page load link
Go to Top
